Your browser doesn't support javascript.
loading
Final results from IMPROVE: a randomized, controlled, open-label, two-arm, cross-over phase IV study to determine patients' preference for everolimus in combination with exemestane or capecitabine in combination with bevacizumab in advanced HR-positive, HER2-negative breast cancer.
Decker, Thomas; Söling, Ulrike; Hahn, Antje; Maintz, Christoph; Kurbacher, Christian Martin; Vehling-Kaiser, Ursula; Sent, Dagmar; Klare, Peter; Hagen, Volker; Chiabudini, Marco; Falkenstein, Julia; Indorf, Martin; Runkel, Eva; Potthoff, Karin.
Afiliação
  • Decker T; Gemeinschaftspraxis für Hämatologie und Onkologie GbR, Elisabethenstrasse 19, 88212, Ravensburg, Germany.
  • Söling U; Onkologische Gemeinschaftspraxis, Goethestrasse 47, 34119, Kassel, Germany.
  • Hahn A; Klinikum Mittelbaden Baden-Baden Bühl, Balger Strasse 50, 76532, Baden-Baden Weststadt, Germany.
  • Maintz C; Hämatologisch-Onkologische Praxis, Mauerfeldchen 72, 52146, Würselen, Germany.
  • Kurbacher CM; Gynäkologisches Zentrum Bonn, Friedenplatz 16, 53111, Bonn, Germany.
  • Vehling-Kaiser U; Hämatologisch-onkologische Tagesklinik, Achdorfer Weg 5, 84036, Landshut, Germany.
  • Sent D; Klinikum Leverkusen gGmbH, Am Gesundheitspark 11, 51375, Leverkusen, Germany.
  • Klare P; MediOnko-Institut GbR, Möllendorffstr. 52, 10367, Berlin, Germany.
  • Hagen V; St.-Johannes-Hospital, Johannesstr. 9-17, 44137, Dortmund, Germany.
  • Chiabudini M; iOMEDICO AG, Ellen-Gottlieb-Straße 19, 79106, Freiburg im Breisgau, Germany.
  • Falkenstein J; iOMEDICO AG, Ellen-Gottlieb-Straße 19, 79106, Freiburg im Breisgau, Germany.
  • Indorf M; iOMEDICO AG, Ellen-Gottlieb-Straße 19, 79106, Freiburg im Breisgau, Germany.
  • Runkel E; iOMEDICO AG, Ellen-Gottlieb-Straße 19, 79106, Freiburg im Breisgau, Germany.
  • Potthoff K; iOMEDICO AG, Ellen-Gottlieb-Straße 19, 79106, Freiburg im Breisgau, Germany. manuscript@iomedico.com.
BMC Cancer ; 20(1): 286, 2020 Apr 06.
Article em En | MEDLINE | ID: mdl-32252684
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de Progesterona / Receptor ErbB-2 / Receptor alfa de Estrogênio / Preferência do Paciente Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de Progesterona / Receptor ErbB-2 / Receptor alfa de Estrogênio / Preferência do Paciente Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article